Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Blood (2022) 139 (3): 384–398.

https://doi.org/10.1182/blood.2020010039

Published: 2022

Includes: Supplemental data

Journal Articles

Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation

Blood (2018) 131 (18): 2036–2046.

https://doi.org/10.1182/blood-2017-09-808907

Published: 2018

Includes: Supplemental data

Journal Articles

A New Immunohistochemical Algorithm Using Four Antibodies Has a High Concordance with Gene Expression Profiling Defined ABC and GCB Diffuse Large B-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 416.

https://doi.org/10.1182/blood.V130.Suppl_1.416.416

Published: 2017

Journal Articles

Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 4118.

https://doi.org/10.1182/blood.V128.22.4118.4118

Published: 2016

Journal Articles

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Blood (2016) 128 (22): 4097.

https://doi.org/10.1182/blood.V128.22.4097.4097

Published: 2016

Journal Articles

Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study

Blood (2015) 126 (23): 1472.

https://doi.org/10.1182/blood.V126.23.1472.1472

Published: 2015

Journal Articles

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

Fabrice Jardin, MD PhD, Anais Pujals, PhD, Laura Pelletier, PhD, Elodie Bohers, PhD, Vincent Camus, Sylvain Mareschal, Sydney Dubois, Marlène Ochman, MD, Francois Lemonnier, MD, Pierre-Julien Viailly, Philippe Bertrand, PhD, Catherine Maingonnat, Alexandra Traverse-Glehen, Philippe Gaulard, MD PhD, Diane Damotte, MD PhD, Richard Delarue, MD, Corinne Haioun, MD PhD, Yosef Landesman, PhD, William Senapedis, PhD, Christian Argueta, PhD, Gilles Andre Salles, MD PhD, Jean-Philippe Jais, MD PhD, Martin Figeac, PhD, Christiane Copie-Bergman, MD PhD, Thierry Molina, Jean-Michel Picquenot, PhD, Marie Cornic, Thierry Fest, MD PhD, Noel Milpied, Emilie Lemasle, MD, Aspasia Stamatoullas, MD, Peter Moeller, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Christer Sundstrom, MD PhD, Christian Bastard, MD PhD, Hervé Tilly, MD PhD, Karen Leroy, MD PhD

Blood (2015) 126 (23): 129.

https://doi.org/10.1182/blood.V126.23.129.129

Published: 2015

Journal Articles

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Blood (2015) 126 (22): 2466–2474.

https://doi.org/10.1182/blood-2015-05-647602

Published: 2015

Includes: Supplemental data

Journal Articles

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Blood (2014) 124 (19): 3016–3019.

https://doi.org/10.1182/blood-2014-04-570937

Published: 2014

Includes: Supplemental data

Journal Articles

Accurate Classification Of GCB/ABC and MYC/BCL2 Diffuse Large B-Cell Lymphoma With a 14 Genes Expression Signature and a Simple and Robust RT-MLPA Assay

Philippe Ruminy, PhD, Sylvain Mareschal, Cristina Bagacean, Vinciane Rainville, Karen Leroy, MD, Jean-Philippe Jais, MD, PhD, Hugo Varet, Martin Figeac, PhD, jean Michel Picquenot, MD, Herve Tilly, MD, Fabrice Jardin, MD, PhD

Blood (2013) 122 (21): 84.

https://doi.org/10.1182/blood.V122.21.84.84

Published: 2013

Journal Articles

Protein Tyrosine Phosphatase Type-1 ( PTPN1 ) Is Frequently Mutated In Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma

Blood (2013) 122 (21): 242.

https://doi.org/10.1182/blood.V122.21.242.242

Published: 2013

Journal Articles

Constitutively Active STAT6 Represses BCL6 in Primary Mediastinal B Cell Lymphoma.

Olga Ritz, Dr. rer. nat., Jochen K Lennerz, MD PhD, Karolin Rommel, MSc, Karola Dorsch, Elena Kelsch, Julia Melzner, Michaela Buck, Karen Leroy, MD, Silke Brüderlein, Dr. hum. biol., Peter Moeller, MD

Blood (2012) 120 (21): 2417.

https://doi.org/10.1182/blood.V120.21.2417.2417

Published: 2012

Journal Articles

Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.

Marlene Ochmann, Francois Lemonnier, Diane Damotte, MD, Richard Delarue, MD, Susana Ben-Neriah, Noel Milpied, MD, Thierry Lamy, MD, PhD, Herve Tilly, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, Philippe Gaulard, MD, Karen Leroy, MD

Blood (2012) 120 (21): 2645.

https://doi.org/10.1182/blood.V120.21.2645.2645

Published: 2012

Journal Articles

BCL2 Negative Follicular Lymphoma with BCL6 Gene Rearrangement Show Mutations of STAT6 DNA Binding Domain

Marlene Ochmann, Christiane Copie-Bergman, Maryse Baia, Philippe Ruminy, Christian Bastard, MD, Corinne Haioun, MD, PhD, Philippe Gaulard, MD, Fabrice Jardin, MD, PhD, Karen Leroy, MD

Blood (2012) 120 (21): 1559.

https://doi.org/10.1182/blood.V120.21.1559.1559

Published: 2012

Journal Articles

Integrated Analysis of High-Resolution Gene Expression and Copy Number Profiling Identified Biallelic Deletion of CDKN2A/2B Tumor Suppressor Locus As the Most Frequent and Unique Genomic Abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with Strong Prognostic Value in Both GCB and ABC Subtypes and Not Overcome by a Dose-Intensive Immunochemotherapy Regimen Plus Rituximab. Results of a Prospective GELA Clinical Trial Program

Fabrice Jardin, MD, PhD, Sylvain Mareschal, Martin Figeac, PhD, Jean-Philippe Jais, MD, Karen Leroy, MD, Christiane Copie-Bergman, MD, Gilles Andre Salles, MD, PhD, Bertrand Coiffier, MD, Richard Delarue, MD, Frederic Peyrade, MD, Andre Bosly, MD, PhD, Nicolas Ketterer, MD, Corinne Haioun, MD, PhD, Herve Tilly, MD, Thierry Jo Molina, MD

Blood (2012) 120 (21): 415.

https://doi.org/10.1182/blood.V120.21.415.415

Published: 2012

Journal Articles

MYC Gene Simple Hit Is a Strong Independent Predictive Factor of Survival in Diffuse Large B-Cell Lymphomas in Contrast to MYC Double-Hit Gene Alterations: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte

Blood (2012) 120 (21): 541.

https://doi.org/10.1182/blood.V120.21.541.541

Published: 2012

Journal Articles

Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program

Blood (2012) 120 (21): 1539.

https://doi.org/10.1182/blood.V120.21.1539.1539

Published: 2012

Journal Articles

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

Thierry Jo Molina, Danielle Canioni, Christiane Copie-Bergman, Christian Recher, MD, PhD, Marion Fournier, Corinne Haioun, Josette Briere, Francoise Berger, Christophe Fermé, Marie-Christine Copin, Rene-Olivier Casasnovas, Catherine Thieblemont, MD, Karen Leroy, Gilles Andre Salles, Fabrice Jardin, Jean-Philippe Jais, Philippe Gaulard, Bertrand Coiffier, Herve Tilly

Blood (2011) 118 (21): 2632.

https://doi.org/10.1182/blood.V118.21.2632.2632

Published: 2011

Journal Articles

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study

Fabrice Jardin, Jean-Philippe Jais, Thierry-Jo Molina, Françoise Parmentier, Jean-Michel Picquenot, Philippe Ruminy, Hervé Tilly, Christian Bastard, Gilles-André Salles, Pierre Feugier, Catherine Thieblemont, Christian Gisselbrecht, Aurelien de Reynies, Bertrand Coiffier, Corinne Haioun, Karen Leroy

Blood (2010) 116 (7): 1092–1104.

https://doi.org/10.1182/blood-2009-10-247122

Published: 2010

Includes: Supplemental data

Journal Articles

Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma

Olga Ritz, Chrystelle Guiter, Flavia Castellano, Karola Dorsch, Julia Melzner, Jean-Philippe Jais, Gwendoline Dubois, Philippe Gaulard, Peter Möller, Karen Leroy

Blood (2009) 114 (6): 1236–1242.

https://doi.org/10.1182/blood-2009-03-209759

Published: 2009

Includes: Supplemental data

NARROW

The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation

A New Immunohistochemical Algorithm Using Four Antibodies Has a High Concordance with Gene Expression Profiling Defined ABC and GCB Diffuse Large B-Cell Lymphoma

Integrated Analysis of IGHV Gene Status, Cell-of-Origin Signature and Genomic Features in Diffuse Large B-Cell Lymphoma

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and Non-L265P Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases

Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease

Accurate Classification Of GCB/ABC and MYC/BCL2 Diffuse Large B-Cell Lymphoma With a 14 Genes Expression Signature and a Simple and Robust RT-MLPA Assay

Protein Tyrosine Phosphatase Type-1 ( PTPN1 ) Is Frequently Mutated In Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma

Constitutively Active STAT6 Represses BCL6 in Primary Mediastinal B Cell Lymphoma.

Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.

BCL2 Negative Follicular Lymphoma with BCL6 Gene Rearrangement Show Mutations of STAT6 DNA Binding Domain

MYC Gene Simple Hit Is a Strong Independent Predictive Factor of Survival in Diffuse Large B-Cell Lymphomas in Contrast to MYC Double-Hit Gene Alterations: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte

Expression of MYC, IgM, As Well As Non-Germinal Centre B-Cell Like Immunophenotype and Positive Immunofish Index Predict a Worse Progression Free Survival and Overall Survival in a Series of 670 De Novo Diffuse Large B-Cell Lymphomas Included in Clinical Trials: A GELA Study of the 2003 Program

R-ACVBP Benefits to Younger Patients with Non-Germinal Centre Diffuse Large B-Cell Lymphoma As Compared to R-CHOP in the GELA Trial LNH03-2B

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study

Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only